FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 260 filers reported holding FATE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $337,935 | +271.3% | 103,029 | +730.8% | 0.00% | – |
Q1 2024 | $91,024 | +38.0% | 12,401 | -29.7% | 0.00% | – |
Q4 2023 | $65,936 | -43.0% | 17,630 | -67.7% | 0.00% | – |
Q3 2023 | $115,607 | -69.8% | 54,531 | -32.1% | 0.00% | – |
Q2 2023 | $382,286 | -79.9% | 80,312 | -76.0% | 0.00% | -100.0% |
Q1 2023 | $1,906,136 | +57.7% | 334,410 | +179.2% | 0.00% | – |
Q4 2022 | $1,208,722 | -49.9% | 119,794 | +11.3% | 0.00% | -100.0% |
Q3 2022 | $2,412,000 | -20.1% | 107,662 | -11.6% | 0.00% | 0.0% |
Q2 2022 | $3,019,000 | -26.8% | 121,817 | +14.6% | 0.00% | 0.0% |
Q1 2022 | $4,123,000 | -30.5% | 106,340 | +4.9% | 0.00% | -50.0% |
Q4 2021 | $5,934,000 | +6.0% | 101,421 | +7.4% | 0.00% | 0.0% |
Q3 2021 | $5,596,000 | +13.2% | 94,424 | +65.8% | 0.00% | 0.0% |
Q2 2021 | $4,944,000 | +16.4% | 56,964 | +10.5% | 0.00% | 0.0% |
Q1 2021 | $4,249,000 | -10.9% | 51,538 | -1.7% | 0.00% | 0.0% |
Q4 2020 | $4,768,000 | +151.7% | 52,430 | +10.7% | 0.00% | +100.0% |
Q3 2020 | $1,894,000 | +143.4% | 47,378 | +109.1% | 0.00% | – |
Q2 2020 | $778,000 | +58.5% | 22,657 | +2.6% | 0.00% | – |
Q1 2020 | $491,000 | -19.0% | 22,076 | -28.7% | 0.00% | – |
Q4 2019 | $606,000 | +43.3% | 30,973 | +13.7% | 0.00% | – |
Q3 2019 | $423,000 | +94.0% | 27,232 | +153.7% | 0.00% | – |
Q2 2019 | $218,000 | +5.8% | 10,732 | -8.5% | 0.00% | – |
Q1 2019 | $206,000 | +41.1% | 11,732 | +3.1% | 0.00% | – |
Q4 2018 | $146,000 | +16.8% | 11,376 | +48.6% | 0.00% | – |
Q3 2018 | $125,000 | +43.7% | 7,657 | 0.0% | 0.00% | – |
Q2 2018 | $87,000 | +4.8% | 7,657 | -10.4% | 0.00% | – |
Q1 2018 | $83,000 | +72.9% | 8,543 | +9.7% | 0.00% | – |
Q4 2017 | $48,000 | +118.2% | 7,785 | +38.4% | 0.00% | – |
Q3 2017 | $22,000 | +22.2% | 5,627 | 0.0% | 0.00% | – |
Q2 2017 | $18,000 | – | 5,627 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 3,379,064 | $11,083,330 | 2.77% |
Redmile Group, LLC | 13,169,057 | $43,194,507 | 2.61% |
SUPERSTRING CAPITAL MANAGEMENT LP | 497,360 | $1,631,341 | 2.06% |
Boxer Capital, LLC | 8,215,910 | $26,948,185 | 1.42% |
Deep Track Capital, LP | 5,572,607 | $18,278,151 | 0.55% |
Vestal Point Capital, LP | 2,000,000 | $6,560,000 | 0.49% |
Bruce & Co., Inc. | 300,000 | $984,000 | 0.32% |
Octagon Capital Advisors LP | 520,800 | $1,708,224 | 0.27% |
Integral Health Asset Management, LLC | 850,000 | $2,788,000 | 0.26% |
Bellevue Group AG | 4,839,779 | $15,874,475 | 0.26% |